Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tony Daniels
Observed names:
Daniels, Tony,
T. Daniels
Institutions:
UCB Pharma (United States),
UCB Pharma (Belgium)
Observed institutions:
The University of Melbourne,
UCB Pharma (United States),
St. Joseph's Children's Hospital,
Murdoch Children's Research Institute,
Austin Health,
UCB Pharma (Belgium)
show all 6
OpenAlex ID:
A5085435208
Efficacy of antiepileptic drugs in adults predicts efficacy in children: A systematic review
2012
·
John M. Pellock
, Wendy J. Carman
, et al.
·
Neurology
·
85
PDF
Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures
2019
·
Viktor Farkas
, Barbara Steinborn
, et al.
·
Neurology
·
70
PDF
Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial
2019
·
Edwin Liu
, Deanne Dilley
, et al.
·
Pediatric Drugs
·
46
PDF
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
2023
·
Vicente Villanueva
, Cédric Laloyaux
, et al.
·
CNS Drugs
·
31
PDF
Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures – An open-label trial
2019
·
Jose A. Ferreira
, Jean-Baptiste Le Pichon
, et al.
·
Seizure
·
30
PDF
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis
2024
·
Jerzy P. Szaflarski
, Hervé Besson
, et al.
·
Journal of Neurology
·
17
PDF
Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studies
2024
·
Edward Faught
, Hervé Besson
, et al.
·
Epilepsy & Behavior
·
12
PDF
Safety, tolerability, and efficacy of adjunctive lacosamide in pediatric patients with epilepsy syndromes associated with generalized seizures: Phase 2, open‐label exploratory trial
2023
·
Stéphane Auvin
, Alexis Arzimanoglou
, et al.
·
Epilepsia
·
8
PDF
PP07.5 – 2252: Safety and tolerability of lacosamide as adjunctive therapy in children with partial-onset seizures
2015
·
J.A. Ferreira
, T. Daniels
, et al.
·
European Journal of Paediatric Neurology
·
4
Tolerability and efficacy of adjunctive lacosamide in children and adolescents with focal seizures in context of presence or absence of sodium-channel blocking AEDs: Post-hoc analysis of a randomized, double-blind, placebo-controlled trial (P5.260)
2018
·
Ingrid E. Scheffer
, Ali Bozorg
, et al.
·
Neurology
·
3
Safety, tolerability, and cognitive and behavioral effects of long-term adjunctive lacosamide in children and adolescents with focal seizures (P1.027)
2018
·
Brian Potter
, Cynthia Beller
, et al.
·
Neurology
·
2
Inhalation as an Efficient Delivery Route of Alprazolam for the Treatment of Acute Seizures: Randomized Study of Staccato® Alprazolam Compared to Oral Alprazolam (P9-9.009)
2025
·
Ronald Goldwater
, Tony Daniels
, et al.
·
Neurology
·
1
12-month Effectiveness and Tolerability of Brivaracetam in Patients with Epilepsy and Cognitive or Psychiatric Comorbidities: Subgroup Data from the International EXPERIENCE Pooled Analysis (P8-1.009)
2024
·
Vicente Villanueva
, Wendyl D’Souza
, et al.
·
Neurology
2628 12-Month effectiveness and tolerability of brivaracetam in the real-world in the international EXPERIENCE pooled analysis: final results and Australian subgroup
2023
·
Wendyl D’Souza
, Edward Faught
, et al.
·
BMJ Neurology Open
PDF
2576 12-Month effectiveness and tolerability of brivaracetam in patients with epilepsy switching from levetiracetam Vs Other antiseizure medications in the real-world
2023
·
Wendyl D’Souza
, Edward Faught
, et al.
·
BMJ Neurology Open
PDF
12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis (P11-1.003)
2023
·
Vicente Villanueva
, Wendyl D’Souza
, et al.
·
Neurology
2315 12-month effectiveness and tolerability of brivaracetam in the real-world: interim analysis of the international, multicenter non-interventional EXPERIENCE study
2022
·
Vicente Villanueva
, Wendyl J D’Souza
, et al.
·
BMJ Neurology Open
PDF
12-month effectiveness and tolerability of brivaracetam in the real-world: interim analysis of the international, non-interventional EXPERIENCE study (P13-8.002)
2022
·
Vicente Villanueva
, Wendyl D’Souza
, et al.
·
Neurology
Show more works
View as search
Works count:
19
Citation count:
309
H-index:
8
I10-index:
7
Year
Topic
Type